Related Experiment Video

Updated: Aug 19, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
09:40

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy

Published on: October 4, 2019

Cytokine- and chemokine-based gene therapy for cancer

Sunil Chada1, Rajagopal Ramesh, Abner M Mhashilkar

  • 1Introgen Therapeutics, 2250 Holcombe Boulevard, Houston, TX 77030, USA. s.chada@introgen.com

Current Opinion in Molecular Therapeutics
|November 7, 2003
PubMed

Insights

Genetic delivery of cytokine genes offers a promising alternative to protein-based therapies for cancer, potentially reducing side effects and improving efficacy. This approach targets various cytokines and chemokines for enhanced immune modulation and antitumor activity.

Area of Science:

  • Immunology
  • Biotechnology
  • Oncology

Background:

  • Cytokines are crucial immune messengers with therapeutic potential but face challenges in systemic delivery due to short half-lives and toxicity.
  • Recombinant cytokine proteins are used for cancer, viral, and autoimmune diseases, yet systemic administration causes severe side effects.
  • Genetic delivery of cytokine genes is being explored to overcome limitations of protein-based therapies.

Purpose of the Study:

  • To review promising cytokines and chemokines under investigation for cancer therapies.
  • To discuss the potential of genetic cytokine delivery as an alternative to protein-based treatments.
  • To examine the role of chemokines in regulating tumor development and their potential as antitumor drugs.

Main Methods:

  • Review of current research on cytokine and chemokine-based cancer therapies.
  • Analysis of cytokines including interleukins (IL-2, IL-4, IL-12, IL-24) and interferons (IFN-alpha, IFN-beta, IFN-gamma).
  • Examination of chemokines (e.g., IP-10, MCP-3, MIG, SDF-1 alpha) for their antitumor properties.

Main Results:

  • Several cytokines (IL-2, IL-4, IL-12, IL-24, IFN-alpha, IFN-beta, IFN-gamma, G-CSF, TNF-alpha) show promise in cancer therapy.
  • Chemokines regulate tumor growth through angiogenesis, immune activation, and direct tumor cell inhibition.
  • ELR-negative chemokines are identified as potential antitumor agents.

Conclusions:

  • Genetic delivery of cytokine genes presents a viable strategy to improve cancer therapy outcomes.
  • Cytokines and chemokines offer diverse mechanisms for modulating the tumor microenvironment and host immunity.
  • Further research into genetic cytokine and chemokine therapies could lead to novel cancer treatments.

More Related Videos

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment11:11

Isolation and Expansion of Cytotoxic Cytokine-induced Killer T Cells for Cancer Treatment

Published on: January 24, 2020

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.